Group One Trading
LPCN icon

Group One Trading’s Lipocine LPCN Stock Holding History

Group One Trading’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-200
Closed -$552 – 7563
2023
Q4 		$552 Buy
200
+100
+100% +$265 ﹤0.01% 7078
2023
Q3 		$294 Hold
100
– – ﹤0.01% 7409
2023
Q2 		$500 Buy
100
+24
+32% +$113 ﹤0.01% 7368
2023
Q1 		$414 Sell
76
-212
-74% -$1.64K ﹤0.01% 6929
2022
Q4 		$1.95K Hold
288
– – ﹤0.01% 6666
2022
Q3 		$2K Buy
288
+76
+36% +$849 ﹤0.01% 7164
2022
Q2 		$3K Sell
212
-700
-77% -$10.9K ﹤0.01% 7303
2022
Q1 		$21K Buy
912
+430
+89% +$9K ﹤0.01% 6717
2021
Q4 		$8K Sell
482
-471
-49% -$8.75K ﹤0.01% 7459
2021
Q3 		$18K Buy
953
+41
+4% +$905 ﹤0.01% 7233
2021
Q2 		$22K Sell
912
-4,294
-82% -$101K ﹤0.01% 7123
2021
Q1 		$134K Buy
+5,206
New +$150K ﹤0.01% 5387
2020
Q4 		– Sell
-135
Closed -$3K – 6774
2020
Q3 		$3K Buy
+135
New +$3.58K ﹤0.01% 5752
2020
Q1 		– Sell
-512
Closed -$3K – 5523
2019
Q4 		$3K Sell
512
-176
-26% -$4.51K ﹤0.01% 4842
2019
Q3 		$33K Sell
688
-488
-41% -$19.6K ﹤0.01% 4171
2019
Q2 		$39K Hold
1,176
– – ﹤0.01% 3901
2019
Q1 		$46K Buy
+1,176
New +$36.1K ﹤0.01% 3605
2018
Q4 		– Sell
-235
Closed -$6K – 5170
2018
Q3 		$6K Sell
235
-1,406
-86% -$34.6K ﹤0.01% 4786
2018
Q2 		$36K Sell
1,641
-159
-9% -$3.79K ﹤0.01% 4117
2018
Q1 		$47K Sell
1,800
-459
-20% -$12.8K ﹤0.01% 3696
2017
Q4 		$132K Buy
+2,259
New +$140K ﹤0.01% 3189
2017
Q3 		– Sell
-76
Closed -$5K – 5001
2017
Q2 		$5K Buy
+76
New +$4.96K ﹤0.01% 4419
2016
Q4 		– Sell
-147
Closed -$11K – 4636
2016
Q3 		$11K Sell
147
-247
-63% -$15.3K ﹤0.01% 4013
2016
Q2 		$20K Buy
394
+206
+110% +$31.9K ﹤0.01% 3799
2016
Q1 		$32K Sell
188
-59
-24% -$10.1K ﹤0.01% 3496
2015
Q4 		$54K Buy
+247
New +$51.8K ﹤0.01% 3357

Other funds holding LPCN

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Group One Trading's LPCN Position: Q1 2026 in Review

Group One Trading reduced its Lipocine (LPCN) stake by 19% in Q1 2026, selling an estimated $261 and leaving 132 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #7208.

Group One Trading first reported a position in LPCN in Q4 2016 and has held it in 25 quarters since. The position peaked at $98K in Q1 2018. 47 funds tracked by Wall St. Rank hold LPCN as of Q1 2026.

  • Group One Trading held 132 shares of Lipocine worth $1.05K as of Q1 2026.
  • Group One Trading sold 30 Lipocine shares in Q1 2026, an estimated $261.
  • Lipocine made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7208 holding.
  • Group One Trading first reported a position in Lipocine in Q4 2016 and has held it in 25 quarters since.
  • Group One Trading's Lipocine position peaked at $98K in Q1 2018.
  • 47 funds tracked by Wall St. Rank held Lipocine as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.